Clinical trial Recruiting at 1 site Interventional Ages 18 to 26

Microvideos to help HPV vaccination for childhood cancer survivors

Official title: Microvideos for Improving HPV Vaccination Among Childhood Cancer Survivors

Run by University of Utah · NCT07648953 · Data updated 2026-11-12

This study tests whether short microvideos can help young adult survivors of childhood cancer decide to get the HPV vaccine, focusing on those in rural Utah who haven’t completed all HPV doses yet.

More HPV Vaccination trials

Quick facts

Study typeInterventional
Ages18 Years to 26 Years
SexAll
Enrollment55 (estimated)
SponsorUniversity of Utah
Academic / other
Locations1 site (Salt Lake City, Utah)
StatusRecruiting
StartedOctober 27, 2026
Main results expectedMay 2027
Study endsMay 2027
Registry record updatedOctober 13, 2026
Trial IDNCT07648953 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are childhood cancer survivors aged 18–26 in Utah who have not completed the HPV vaccine and use Facebook or are willing to use it for the study.

Probably not a fit

Patients who are fully vaccinated, do not use Facebook, or do not reside in or travel to Utah rural areas may see limited or no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This exploratory mixed-methods study uses existing survey data, cancer registry information, and patient interviews to understand how factors such as travel burden, finances, health literacy, and other local conditions influence where survivors receive care and whether they pursue HPV vaccination. It employs a Conceptual Model of Healthcare Access to guide analysis within a Utah rural setting, with potential relevance to other states facing similar geographic and healthcare challenges. The intervention consists of microvideos designed to educate and motivate vaccination, evaluated across Aim 1 focus groups and Aim 2 social media delivery to assess feasibility and reach among unvaccinated survivors aged 18–26. Participants must be childhood cancer survivors diagnosed by age 26 and not yet fully vaccinated, with English proficiency and Facebook access required. The University of Utah leads the trial with collaboration from the Prevent Cancer Foundation and Huntsman Cancer Institute.

Why it matters

Potential benefit: If successful, the microvideos could increase HPV vaccination uptake among rural childhood cancer survivors, potentially reducing HPV-related cancer risk.

How similar studies have gone: Prior education campaigns using digital media have shown promise in improving vaccine intent in some populations, though this exact microvideo approach for rural childhood cancer survivors is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Eligible participants include cancer survivors who are currently ages 18-26 years and who were diagnosed with childhood cancer (ages 0-26 at diagnosis) in the past ten years.
* Currently use Facebook or willing to create a Facebook account to use for the duration of the study.
* At the time of enrollment, have not completed all recommended doses of the HPV vaccine.

Exclusion Criteria:

* Unable to speak and understand English.
* Participants who take part in the Aim 1 focus groups will be ineligible for the Aim 2 social media group.
* Participants who are fully vaccinated for HPV will be ineligible as the goal of Aim 2 is to evaluate the feasibility of the social media campaign for improving vaccine intention among HPV unvaccinated individuals.

Where it's running

  • University of Utah
    Salt Lake City, Utah, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.